Edick Paul R 4
4 · Vistagen Therapeutics, Inc. · Filed Nov 4, 2025
Insider Transaction Report
Form 4
Edick Paul R
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-10-27+35,200→ 35,200 totalExercise: $3.90Exp: 2035-10-27→ Common Stock (35,200 underlying)
Footnotes (1)
- [F1]Represents stock options granted in connection with the reporting person's appointment to the Issuer's Board of Directors. The stock options were granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, and vest in three equal annual installments, beginning on the first anniversary of the date of the grant.